Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis
Stefan Buettner, Sing Yu Moorcraft(National Health Service), Andrew Ko(University of California, San Francisco), Marc G. Besselink(Amsterdam Neuroscience), Brian A. Boone(West Virginia University), Jessica M. Frakes(Moffitt Cancer Center), Ian Chau(Royal Marsden NHS Foundation Trust), Georgios Antonios Margonis(Memorial Sloan Kettering Cancer Center), Pietro Addeo(Hôpitaux Universitaires de Strasbourg), Mary Dillhoff(The Ohio State University Wexner Medical Center), P. Bachellier(Hôpitaux Universitaires de Strasbourg), Jill Lacy(Smilow Cancer Hospital), Bassel F. El‐Rayes(University of Alabama at Birmingham), Quisette P. Janssen, Peter J. Hosein(Markey Cancer Center), S. Kim(University of California, San Francisco), Berend R. Beumer(Erasmus University Rotterdam), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Eric A. Mellon(Henry Ford Health System), Nigel B. Jamieson(University of Glasgow), Nathan Bahary(University of Pittsburgh Medical Center), Stephen Clarke(The University of Sydney), Tanios Bekaii‐Saab(WinnMed), C. McKay(University of Southampton), Derek Grose, Ammar A. Javed(NYU Langone Health), Khurram J Khan(Royal Marsden NHS Foundation Trust), Mustafa Suker(Erasmus MC Cancer Institute), Martin McCarter, K. Kim(Asan Medical Center)
Cited by 8
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k